Blue Calypso, Inc.

Equities

BCYP

US09531B3024

Software

Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for Blue Calypso, Inc. -.--% -.--%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Blue Calypso : SAB Biotherapeutics Listed on Nasdaq After Completing Merger With Big Cypress Acquisition MT
Blue Calypso : Big Cypress Acquisition Shareholders Approve Merger With SAB Biotherapeutics MT
Insider Buy: Big Cypress Acquisition MT
BLUE CALYPSO : Northland Capital Markets Starts Big Cypress Acquisition Corp at Outperform with $18 Price Target MT
BLUE CALYPSO : Ladenburg Thalmann Initiates Big Cypress Acquisition at Buy Rating With $16.50 Price Target MT
Blue Calypso : SAB Biotherapeutics Gets Safety Monitoring Board's Recommendation to Advance COVID-19 Drug Candidate to Phase 3 Trial MT
Blue Calypso : Big Cypress Acquisition Sets Shareholder Vote to Approve Merger With SAB Biotherapeutics MT
Blue Calypso : SAB Biotherapeutics Awarded Additional $60.5 Million by Defense Department for COVID-19 Drug Candidate Program MT
BIG CYPR : Cypress Acquisition Closes $115 Million Initial Public Offering MT
Blue Calypso To Explore Strategic Alternatives CI
Transcript : Blue Calypso, Inc., Q3 2016 Earnings Call, Nov 10, 2016
Blue Calypso, Inc. Reports Unaudited Consolidated Financial Results for the Third Quarter and Nine Months Ended September 30, 2016 CI
Blue Calypso, Inc. Announces Management Changes CI
Blue Calypso, Inc. Announce the Resignation of Melisse Shaban as Member of the Board of Directors CI
Transcript : Blue Calypso, Inc., Q2 2016 Earnings Call, Aug 10, 2016
Blue Calypso, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2016 CI
Blue Calypso, Inc. Appoints Harold Hal Brierley as Chairman of the Board CI
Blue Calypso, Inc. Reports Unaudited Consolidated Earnings Results for Its First Quarter Ended March 31, 2016 CI
Transcript : Blue Calypso, Inc., Q1 2016 Earnings Call, May 16, 2016
Blue Calypso, Inc. announced that it has received $1 million in funding CI
Blue Calypso, Inc. Reports Earnings Results for the Year Ended December 31, 2015 CI
Transcript : Blue Calypso, Inc., Q4 2015 Earnings Call, Mar 22, 2016
Blue Calypso, Inc. announced that it has received $0.05 million in funding CI
Blue Calypso, Inc. announced that it has received $0.35 million in funding CI
Blue Calypso, Inc. announced that it expects to receive $0.35 million in funding CI
Chart Blue Calypso, Inc.
More charts
Blue Calypso, Inc. is a United States-based company. The Company develops and delivers mobile shopper marketing and analytics solutions for the business-to-consumer (B2C) marketplace leveraging mobile, social media, gamification and intellectual property portfolio. The Company offers, KIOSENTRIX, provides manufacturers and brick-and-mortar retailers with a personalized way of engaging with store visitors when they are on the path-to-purchase. Its platform allows the collection of business intelligence and analytics resulting from data accumulated as content is deployed, adopted, consumed and shared. Its technology allows the brand/advertiser to monitor the full cycle of a campaign, from the first engagement to the final redemption or intent to purchase. In addition, the Company offers outsourced consulting and customized software development services through Blue Calypso Labs services.
More about the company
  1. Stock Market
  2. Equities
  3. BCYP Stock
  4. News Blue Calypso, Inc.
  5. Blue Calypso : SAB Biotherapeutics Awarded Additional $60.5 Million by Defense Department for COVID-19 Drug Candidate Program